Vestal Point Capital, LP Fulcrum Therapeutics, Inc. Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,160,000 shares of FULC stock, worth $3.72 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
1,160,000
Previous 695,000
66.91%
Holding current value
$3.72 Million
Previous $6.56 Billion
9.62%
% of portfolio
0.54%
Previous 0.54%
Shares
3 transactions
Others Institutions Holding FULC
# of Institutions
137Shares Held
59.2MCall Options Held
4.33MPut Options Held
309K-
Ra Capital Management, L.P. Boston, MA11.6MShares$37.3 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$18.8 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$15.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$9.86 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$9.51 Million0.47% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $167M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...